. "Appendix A Agenda." Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington, DC: The National Academies Press, 2007.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary
Appendix A
Agenda
Ethical and Legal Considerations in Mitigating Pandemic Disease
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole. Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 203
Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary
Appendix A
Agenda
Ethical and Legal Considerations in Mitigating Pandemic Disease
PAHO Headquarters—Conference Room A
525 23rd Street, NW
Washington, D.C.
September 19-20, 2006
AGENDA
Tuesday, September 19, 2006
8:30 a.m.
Continental Breakfast
9:00 a.m.
Welcome and Opening Remarks
Stanley M. Lemon, M.D., Chair,
Forum on Microbial Threats
9:15–10:00 a.m.
KEYNOTE ADDRESS: “Past as Prologue?”
David Heymann, M.D.,
World Health Organization
10:00–10:15 a.m.
Discussion
OCR for page 204
Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary
Session I:
Understanding the Challenges of the Future by Examining the Past: Influenza/Smallpox/SARS
Moderator: Ruth Berkelman, M.D., Emory University,
Rollins School of Public Health
10:15–11:00 a.m.
Contemplating Pandemics: The Role of Historical
Inquiry in Developing Pandemic-Mitigation Strategies for the Twenty-First Century
Howard Markel, M.D., University of Michigan
11:00–11:45 a.m.
The Smallpox Eradication Campaign
D.A. Henderson, M.D., Center for Biosecurity,
University of Pittsburgh Medical Center
11:45 a.m.–12:30 p.m.
Lessons from SARS
David Heymann, M.D., World Health Organization
12:30–1:00 p.m.
Session I Q&A
1:00–1:45 p.m.
LUNCH
Session II:
Domestic, Regional, and International Preparedness Planning
Moderator: P. Frederick Sparling, M.D., Vice Chair,
Forum on Microbial Threats
1:45–2:30 p.m.
U.S. Government Preparedness Plans
Bruce Gellin, M.D., Office of the Secretary,
Department of Health and Human Services
2:30–3:15 p.m.
Regional Planning Efforts
Oscar J. Mujica, M.D., M.P.H., P.H.E.,
Pan American Health Organization
3:15–3:45 p.m.
Q&A
3:45–4:00 p.m.
BREAK
4:00–4:45 p.m.
Ethical Considerations in International Preparedness
Planning Efforts
Alexander Morgan Capron, University of Southern
California
OCR for page 205
Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary
4:45–5:15 p.m.
Open Discussion of Session II
5:15–6:00 p.m.
Open Discussion of Day 1
6:00 p.m.
Adjourn
Wednesday, September 20, 2006
8:00 a.m.
Continental Breakfast
8:30 a.m.
Opening Remarks/Summary of Day 1:
Margaret A. Hamburg, M.D.,
Vice Chair, Forum on Microbial Threats
Session III:
Disease Mitigation Strategies–Quarantine, Containment and Modeling
Moderator: Gary Roselle, M.D., Program Director for Infectious Diseases,
Department of Veterans Affairs Central Office
8:45–9:30 a.m.
Public Health and Ethical Considerations in
Planning for Quarantine
Martin Cetron, M.D.,
Centers for Disease Control and Prevention
9:30–10:15 a.m.
Preparing for Pandemic Influenza:
Legal and Ethical Challenges
Lawrence Gostin, J.D.,
Georgetown University School of Law
10:15–10:30 a.m.
Discussion
10:30–11:15 a.m.
The Role of Modeling in Infectious Disease
Mitigation and Containment
Joshua Epstein, Ph.D., The Brookings Institution
11:15–11:45 a.m.
Discussion Panel:
Timothy C. Germann, Ph.D., Los Alamos National Laboratory
James LeDuc, M.D., Centers for Disease Control and Prevention
Victoria Sutton, J.D., Ph.D., Texas Tech University School of Law
OCR for page 206
Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary
11:45 a.m.–12:30 p.m.
Lunch
12:30–1:30 p.m.
Luncheon Remarks
Harvey V. Fineberg, M.D., Ph.D.,
President, Institute of Medicine
Session IV:
Ethical Issues in Pandemic Planning and Response
Moderator: Stanley M. Lemon, M.D., Chair, Forum on Microbial Threats
1:30–2:15 p.m.
Intensive Care Unit Triage During an Influenza
Pandemic: The Need for Specific Clinical Guidelines
Bernard Lo, M.D.,
University of California, San Francisco
2:15–3:00 p.m.
Social Justice and Pandemic Planning and Response
Ruth Faden, Ph.D.,
Berman Bioethics Institute, Johns Hopkins University
3:00–3:45 p.m.
Discussion Panel:
Steven Bice, Battelle, Atlanta, Georgia
D.A. Henderson, M.D., Center for Biosecurity, University of Pittsburgh Medical Center
Shelley Hearne, D.P.H., Johns Hopkins University
3:45–4:30 p.m.
Open Discussion
4:30–4:45 p.m.
Closing Remarks/Adjourn
